Inventiva (IVA) Enterprise Value (2018 - 2025)
Inventiva (IVA) posted quarterly Enterprise Value of -$268.8 million for Q4 2025, down 160.39% year-over-year from $445.1 million in Q4 2024, and down 78.75% quarter-over-quarter from -$150.4 million in Q2 2025.
Inventiva (IVA) Enterprise Value (2018 - 2025) Analysis & Trends
Inventiva's Enterprise Value history runs 8 years deep, the most recent figure standing at -$268.8 million for Q4 2025.
- In Q4 2025, Enterprise Value fell 160.39% year-over-year to -$268.8 million; the TTM figure through Dec 2025 stood at -$268.8 million (down 160.39% YoY), while the FY2025 annual figure was -$268.8 million, down 160.39% from the prior year.
- Enterprise Value for Q4 2025 stood at -$268.8 million, down from -$150.4 million in the prior quarter.
- The five-year high for Enterprise Value was -$11.8 million in Q2 2024, with the low at -$268.8 million in Q4 2025.
- The 5-year median for Enterprise Value is -$93.8 million (2021), against an average of -$93.7 million.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value soared 67.62% in 2024, then sank 1174.49% in 2025.
- Inventiva's Enterprise Value stood at -$99.0 million in 2021, then climbed by 10.63% to -$88.5 million in 2022, then surged by 67.19% to -$29.0 million in 2023, then tumbled by 255.49% to -$103.2 million in 2024, then slumped by 160.39% to -$268.8 million in 2025.
- Business Quant data shows IVA's Enterprise Value at -$268.8 million in Q4 2025, -$150.4 million in Q2 2025, and -$103.2 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Inventiva | 888.89 Mn | 888.89 Mn | - | -268.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -268.79 Mn |
| Jun 30, 2025 | -150.37 Mn |
| Dec 31, 2024 | -103.23 Mn |
| Jun 30, 2024 | -11.80 Mn |
| Dec 31, 2023 | -29.04 Mn |
| Oct 11, 2023 | -12.54 Mn |
| Jun 30, 2023 | -36.44 Mn |
| Dec 31, 2022 | -88.49 Mn |
| Jun 30, 2022 | -81.53 Mn |
| Dec 31, 2021 | -99.01 Mn |
| Jun 30, 2021 | -112.76 Mn |
| Mar 31, 2021 | -130.04 Mn |
| Dec 31, 2020 | -126.01 Mn |
| Jun 30, 2020 | -57.58 Mn |
| Dec 31, 2019 | -39.67 Mn |
| Dec 31, 2018 | -64.71 Mn |